{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:50:04Z","timestamp":1788357004630,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The outcome of the sentinel lymph node in breast cancer patients affects adjuvant treatment. Compared to conventional histopathology, analysis by one-step nucleic acid amplification (OSNA) harvests more micrometastasis, potentially inducing overtreatment. In this study we investigated the impact of OSNA analysis on adjuvant treatment, compared to histopathological analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from T1\u20133 breast cancer patients with sentinel nodes analysed between January 2016 and December 2019 by OSNA (OSNA group, <jats:italic>n<\/jats:italic>\u2009=\u20091086) from Zuyderland Medical Centre, the Netherlands, were compared to concurrent data from the Netherlands Cancer Registry (NKR) where sentinel nodes were examined by histology (histology group, n\u2009=\u200935,143). Primary outcomes were micro- or macrometastasis, axillary treatments (axillary lymph node dissection (ALND) or axillary radiotherapy (ART)), chemotherapy, and endocrine therapy. Statistics with Pearson Chi-square.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the OSNA group more micrometastasis (14.9%) were detected compared to the histology group (7.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). No difference in axillary treatment between groups was detected (14.3 vs. 14.4%). In case of mastectomy and macrometastasis, ALND was preferred over ART in the OSNA group (14.9%) compared to the histology group (4.4%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In cases of micrometastasis, no difference was seen. There was no difference in administration of adjuvant chemotherapy between groups. Endocrine treatment was administrated less often in the OSNA group compared to the histology group (45.8% vs. 50.8%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>More micrometastasis were detected by OSNA compared to histopathology, but no subsequent increase in adjuvant axillary and systematic treatment was noticed. When performing mastectomy and OSNA, there was a preference for ALND compared to ART.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10549-023-07065-0","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T02:01:16Z","timestamp":1690423276000},"page":"245-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-2445","authenticated-orcid":false,"given":"Elisabeth R. M.","family":"van Haaren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid G. M.","family":"Poodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel A.","family":"Spiekerman van Weezelenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"van Bastelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B. I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee H.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne L. J.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"7065_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol 35:561\u2013564. https:\/\/doi.org\/10.1200\/JCO.2016.71.0947","journal-title":"J Clin Oncol"},{"key":"7065_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1008108","volume":"364","author":"DL Weaver","year":"2011","unstructured":"Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412\u2013421. https:\/\/doi.org\/10.1056\/NEJMoa1008108","journal-title":"N Engl J Med"},{"key":"7065_CR3","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471\u20131474. https:\/\/doi.org\/10.1245\/s10434-010-0985-4","journal-title":"Ann Surg Oncol"},{"key":"7065_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12282-012-0390-x","volume":"22","author":"Y Tamaki","year":"2015","unstructured":"Tamaki Y (2015) One-step nucleic acid amplification assay (OSNA) for sentinel lymph node biopsy. Breast Cancer 22:230\u2013234. https:\/\/doi.org\/10.1007\/s12282-012-0390-x","journal-title":"Breast Cancer"},{"key":"7065_CR5","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1158\/1078-0432.CCR-06-2512","volume":"13","author":"M Tsujimoto","year":"2007","unstructured":"Tsujimoto M, Nakabayashi K, Yoshidome K et al (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13:4807\u20134816. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2512","journal-title":"Clin Cancer Res"},{"key":"7065_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.5858\/arpa.2020-0411-OA","volume":"145","author":"R Czaja","year":"2021","unstructured":"Czaja R, Wu R, Jorns JM (2021) Breast sentinel lymph node frozen section practice: an enterprise audit as a guide for moving forward. Arch Pathol Lab Med 145:1018\u20131024. https:\/\/doi.org\/10.5858\/arpa.2020-0411-OA","journal-title":"Arch Pathol Lab Med"},{"key":"7065_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/cncr.25606","volume":"117","author":"LC Liu","year":"2011","unstructured":"Liu LC, Lang JE, Lu Y et al (2011) Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer 117:250\u2013258. https:\/\/doi.org\/10.1002\/cncr.25606","journal-title":"Cancer"},{"key":"7065_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/bjs.7347","volume":"98","author":"KL Snook","year":"2011","unstructured":"Snook KL, Layer GT, Jackson PA et al (2011) Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 98:527\u2013535. https:\/\/doi.org\/10.1002\/bjs.7347","journal-title":"Br J Surg"},{"key":"7065_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/mco.2017.1404","volume":"7","author":"V Fung","year":"2017","unstructured":"Fung V, Kohlhardt S, Vergani P et al (2017) Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay. Mol Clin Oncol 7:755\u2013762. https:\/\/doi.org\/10.3892\/mco.2017.1404","journal-title":"Mol Clin Oncol"},{"key":"7065_CR10","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L et al (2017) Effect of axillary dissection vs no axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA 318:918\u2013926. https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA"},{"key":"7065_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"key":"7065_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10549-014-3108-2","volume":"147","author":"IT Rubio","year":"2014","unstructured":"Rubio IT, Espinosa-Bravo M, Rodrigo M et al (2014) Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients. Breast Cancer Res Treat 147:371\u2013380. https:\/\/doi.org\/10.1007\/s10549-014-3108-2","journal-title":"Breast Cancer Res Treat"},{"key":"7065_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.suronc.2020.09.010","volume":"35","author":"KFH Hintzen","year":"2020","unstructured":"Hintzen KFH, de Rooij L, Schouten N et al (2020) Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): does not lead to overtreatment in the current era of de-escalating axillary management. Surg Oncol 35:224\u2013228. https:\/\/doi.org\/10.1016\/j.suronc.2020.09.010","journal-title":"Surg Oncol"},{"key":"7065_CR14","doi-asserted-by":"publisher","first-page":"847858","DOI":"10.3389\/fonc.2022.847858","volume":"12","author":"S Bertozzi","year":"2022","unstructured":"Bertozzi S, Londero AP, Bulfoni M et al (2022) One-Step nucleic acid amplification system in comparison to the intraoperative frozen section and definitive histological examination among breast cancer patients: a retrospective survival study. Front Oncol 12:847858. https:\/\/doi.org\/10.3389\/fonc.2022.847858","journal-title":"Front Oncol"},{"key":"7065_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00595-015-1168-5","volume":"46","author":"K Shimazu","year":"2016","unstructured":"Shimazu K, Noguchi S (2016) Clinical significance of breast cancer micrometastasis in the sentinel lymph node. Surg Today 46:155\u2013160. https:\/\/doi.org\/10.1007\/s00595-015-1168-5","journal-title":"Surg Today"},{"key":"7065_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M et al (2013) Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol 20:120\u2013127. https:\/\/doi.org\/10.1245\/s10434-012-2569-y","journal-title":"Ann Surg Oncol"},{"key":"7065_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495\u20131499. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","journal-title":"Int J Surg"},{"key":"7065_CR18","unstructured":"NABON (2017) Richtlijn: Borstkanker. URL:\u00a0https:\/\/www.vkgn.org\/files\/5035\/Richtlijn%20Mammacarcinoom%20(NABONCBOVKGN,%202017).pdf."},{"key":"7065_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00428-021-03128-z","volume":"480","author":"G Cserni","year":"2022","unstructured":"Cserni G, Maguire A, Bianchi S et al (2022) Sentinel lymph node assessment in breast cancer-an update on current recommendations. Virchows Arch 480:95\u2013107. https:\/\/doi.org\/10.1007\/s00428-021-03128-z","journal-title":"Virchows Arch"},{"key":"7065_CR20","unstructured":"Federatie Medisch Specialisten (2021) Borstkanker-Adjuvante Systeemtherapie. . https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/adjuvante_systemische_therapie.html"},{"key":"7065_CR21","unstructured":"Federatie Medisch Specialisten (2021) Borstkanker - Regionale behandeling. URL:\u00a0https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/invasief_carcinoom\/regionale_behandeling_stadium_i_ii.html."},{"key":"7065_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jamcollsurg.2016.04.048","volume":"223","author":"AE Cyr","year":"2016","unstructured":"Cyr AE, Tucker N, Ademuyiwa F et al (2016) Successful completion of the pilot phase of a randomized controlled trial comparing sentinel lymph node biopsy to no further axillary staging in patients with clinical T1\u2013T2 N0 breast cancer and normal axillary ultrasound. J Am Coll Surg 223:399\u2013407. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2016.04.048","journal-title":"J Am Coll Surg"},{"key":"7065_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","volume":"21","author":"O Gentilini","year":"2012","unstructured":"Gentilini O, Veronesi U (2012) Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast 21:678\u2013681. https:\/\/doi.org\/10.1016\/j.breast.2012.06.013","journal-title":"Breast"},{"key":"7065_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","volume":"17","author":"LM van Roozendaal","year":"2017","unstructured":"van Roozendaal LM, Vane MLG, van Dalen T et al (2017) Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013\u201308). BMC Cancer 17:459\u2013x. https:\/\/doi.org\/10.1186\/s12885-017-3443-x","journal-title":"BMC Cancer"},{"key":"7065_CR25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1245\/s10434-010-1451-z","volume":"18","author":"PD Gobardhan","year":"2011","unstructured":"Gobardhan PD, Elias SG, Madsen EV et al (2011) Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol 18:1657\u20131664. https:\/\/doi.org\/10.1245\/s10434-010-1451-z","journal-title":"Ann Surg Oncol"},{"key":"7065_CR26","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1200\/JCO.2008.19.0686","volume":"27","author":"NM Hansen","year":"2009","unstructured":"Hansen NM, Grube B, Ye X et al (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27:4679\u20134684. https:\/\/doi.org\/10.1200\/JCO.2008.19.0686","journal-title":"J Clin Oncol"},{"key":"7065_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-010-1086-6","volume":"127","author":"AJ Maaskant-Braat","year":"2011","unstructured":"Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al (2011) Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat 127:195\u2013203. https:\/\/doi.org\/10.1007\/s10549-010-1086-6","journal-title":"Breast Cancer Res Treat"},{"key":"7065_CR28","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1200\/JCO.2009.24.5001","volume":"28","author":"Y Andersson","year":"2010","unstructured":"Andersson Y, Frisell J, Sylvan M et al (2010) Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 28:2868\u20132873. https:\/\/doi.org\/10.1200\/JCO.2009.24.5001","journal-title":"J Clin Oncol"},{"key":"7065_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M de Boer","year":"2009","unstructured":"de Boer M, van Deurzen CH, van Dijck JA et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653\u2013663. https:\/\/doi.org\/10.1056\/NEJMoa0904832","journal-title":"N Engl J Med"},{"key":"7065_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol 14:297\u2013305. https:\/\/doi.org\/10.1016\/S1470-2045(13)70035-4","journal-title":"Lancet Oncol"},{"key":"7065_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G et al (2018) Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u201301): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol 19:1385\u20131393. https:\/\/doi.org\/10.1016\/S1470-2045(18)30380-2","journal-title":"Lancet Oncol"},{"key":"7065_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann Surg 252:426\u20133. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32","journal-title":"Ann Surg"},{"key":"7065_CR33","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S et al (2019) Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 30:1194\u20131220. https:\/\/doi.org\/10.1093\/annonc\/mdz173","journal-title":"Ann Oncol"},{"key":"7065_CR34","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303\u20131310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"key":"7065_CR35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01565","author":"SAL Bartels","year":"2022","unstructured":"Bartels SAL, Donker M, Poncet C et al (2022) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981\u201322023 AMAROS trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.22.01565","journal-title":"J Clin Oncol"},{"key":"7065_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.critrevonc.2010.05.010","volume":"79","author":"BL Van Leeuwen","year":"2011","unstructured":"Van Leeuwen BL, Rosenkranz KM, Feng LL et al (2011) The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79:315\u2013320. https:\/\/doi.org\/10.1016\/j.critrevonc.2010.05.010","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 2","key":"7065_CR37","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1186\/1471-2482-13-S2-S26","volume":"13","author":"N Rocco","year":"2013","unstructured":"Rocco N, Rispoli C, Pagano G et al (2013) Undertreatment of breast cancer in the elderly. BMC Surg 13(Suppl 2):S26\u2013S26. https:\/\/doi.org\/10.1186\/1471-2482-13-S2-S26","journal-title":"BMC Surg"},{"key":"7065_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-006-9321-x","volume":"102","author":"C Owusu","year":"2007","unstructured":"Owusu C, Lash TL, Silliman RA (2007) Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 102:227\u2013236. https:\/\/doi.org\/10.1007\/s10549-006-9321-x","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-07065-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-07065-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T19:04:46Z","timestamp":1694977486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-07065-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["7065"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-07065-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is an observational study, and no ethical approval was requested.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}